Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

3.39
BATS BZX Real-Time Price
As of 2:51pm ET
 +0.09 / +2.73%
Today’s Change
0.84
Today|||52-Week Range
6.63
+151.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$166.4M

Company Description

Infinity Pharmaceuticals, Inc. is an innovative drug discovery and development company, which engages in discovering, developing and delivering medicines for difficult-to-treat diseases, developing novel small molecule drugs that target emerging disease pathways. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.

Contact Information

Infinity Pharmaceuticals, Inc.
784 Memorial Drive
Cambridge Massachusetts 02139
P:(617) 453-1000
Investor Relations:
(617) 453-1336

Employees

Shareholders

Other institutional54.83%
Individual stakeholders36.19%
Mutual fund holders23.83%

Top Executives

Adelene Q. PerkinsChairman & Chief Executive Officer
Lawrence E. BlochPresident, EVP, Chief Financial & Business Officer
Jeffery KutokChief Scientific Officer
Seth TaskerSecretary, Vice President & General Counsel
James R. PorterSenior Director-Product Development